71 – 80 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Distribution of von Willebrand factor levels in young women with and without bleeding symptoms. Influence of ABO blood group and promoter haplotypes
(
- Contribution to journal › Article
-
Mark
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease
(
- Contribution to journal › Article
-
Mark
FactorVIIa and its potential therapeutic use in bleeding-associated pathologies
(
- Contribution to journal › Article
-
Mark
Cost and outcome: comparisons of two alternative bypassing agents for persons with haemophilia A complicated by an inhibitor.
(
- Contribution to journal › Article
-
Mark
High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)
(
- Contribution to journal › Article
-
Mark
Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Plasma-derived biological medicines used to promote haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Platelets play a direct role in sepsis-associated endothelial cell death
(
- Contribution to journal › Debate/Note/Editorial
- 2007
-
Mark
Haemostasis, vascular biology, and infectious agents.
(
- Contribution to journal › Letter
-
Mark
Coagulation factorV and thrombophilia: Background and mechanisms
(
- Contribution to journal › Article